171 filings
D
SLS
SELLAS Life Sciences Group Inc
29 Mar 24
$18.37 mm in options / securities to be acquired, sold $18.37 mm, 4 investors
4:00pm
S-3
SLS
SELLAS Life Sciences Group Inc
Shelf registration
28 Mar 24
4:51pm
S-3
SLS
SELLAS Life Sciences Group Inc
Shelf registration
28 Mar 24
4:46pm
424B5
SLS
SELLAS Life Sciences Group Inc
18 Mar 24
Prospectus supplement for primary offering
4:37pm
S-8
ozb3iaf
19 Jan 24
Registration of securities for employees
4:11pm
424B5
1bw1ps4i0kwjqyas386
5 Jan 24
Prospectus supplement for primary offering
4:27pm
424B5
gf4 wzozm1u
3 Jan 24
Prospectus supplement for primary offering
8:27pm
424B5
fo1q0f lm3
1 Nov 23
Prospectus supplement for primary offering
4:05pm
S-8
ffy3os
16 Mar 23
Registration of securities for employees
4:20pm
424B5
gph3ri
24 Feb 23
Prospectus supplement for primary offering
5:09pm
424B5
3bui7bg428miu
23 Feb 23
Prospectus supplement for primary offering
4:09pm
S-8
mm2r3 yaw
12 May 22
Registration of securities for employees
5:16pm
424B5
o4lfrc2w0r6bh0gtj
1 Apr 22
Prospectus supplement for primary offering
5:04pm
424B5
25dheocv
31 Mar 22
Prospectus supplement for primary offering
4:31pm
S-8
5j7m y887k
13 Aug 21
Registration of securities for employees
4:05pm
424B5
kpmzwn3d8ihumyd4sc
14 Dec 20
Prospectus supplement for primary offering
5:26pm
D
gd7z u5h2lfmwl
31 Aug 20
$9.15M in equity / options, sold $9.15M, 11 investors
4:03pm